Your browser doesn't support javascript.
loading
Haematopoietic stem cell transplantation for refractory Langerhans cell histiocytosis: outcome by intensity of conditioning.
Veys, Paul A; Nanduri, Vasanta; Baker, K Scott; He, Wensheng; Bandini, Giuseppe; Biondi, Andrea; Dalissier, Arnaud; Davis, Jeffrey H; Eames, Gretchen M; Egeler, R Maarten; Filipovich, Alexandra H; Fischer, Alain; Jürgens, Herbert; Krance, Robert; Lanino, Edoardo; Leung, Wing H; Matthes, Susanne; Michel, Gérard; Orchard, Paul J; Pieczonka, Anna; Ringdén, Olle; Schlegel, Paul G; Sirvent, Anne; Vettenranta, Kim; Eapen, Mary.
Afiliação
  • Veys PA; Great Ormond Street Hospital for Children NHS Trust, London, UK.
  • Nanduri V; Watford General Hospital, Watford, UK.
  • Baker KS; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • He W; CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Bandini G; Institute of Haematology, St. Orsola University Hospital, Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Biondi A; Ospedale San Gerardo, Monza, Italy.
  • Dalissier A; EBMT Paediatric Disease Working Party, Paris, France.
  • Davis JH; British Columbia's Children's Hospital, Vancouver, BC, Canada.
  • Eames GM; Cook Children's Medical Center, Fort Worth, TX, USA.
  • Egeler RM; The Hospital for Sick Children, Toronto, ON, Canada.
  • Filipovich AH; Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Fischer A; Hôpital Necker-Enfants malades, Paris, France.
  • Jürgens H; Klinik/Poliklinik für Kinderheilkunde, Münster, Germany.
  • Krance R; Section of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine and the Center for Cell and Gene Therapy, Houston, TX, USA.
  • Lanino E; Institute G. Gaslini, Genova, Italy.
  • Leung WH; St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Matthes S; St. Anna Kinderspital, Vienna, Austria.
  • Michel G; Hôpital d'Enfants de la Timone, Marseille, France.
  • Orchard PJ; Department of Pediatrics, University of Minnesota Medical Center, Minneapolis, MN, USA.
  • Pieczonka A; Department of Paediatric Oncology, Haematology & HSCT, Poznan, Poland.
  • Ringdén O; Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Schlegel PG; Centre for Allogeneic Stem Cell Transplantation, Stockholm, Sweden.
  • Sirvent A; Department of Paediatric Haematology, Oncology, Paediatric Stem Cell Transplantation Program, University Children's Hospital Wuerzburg, Wuerzburg, Germany.
  • Vettenranta K; Hôpital Arnaud de Villeneuve, CHRU Montpellier, Montpellier, France.
  • Eapen M; University of Helsinki, Helsinki, Finland.
Br J Haematol ; 169(5): 711-8, 2015 Jun.
Article em En | MEDLINE | ID: mdl-25817915

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Histiocitose de Células de Langerhans / Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Br J Haematol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Histiocitose de Células de Langerhans / Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Br J Haematol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Reino Unido